Glucose metabolism and Alzheimer's disease

[1]  R. Hata,et al.  Protective effect of vitamin E against focal brain ischemia and neuronal death through induction of target genes of hypoxia-inducible factor-1 , 2004, Neuroscience.

[2]  Fahmeed Hyder,et al.  Energetic basis of brain activity: implications for neuroimaging , 2004, Trends in Neurosciences.

[3]  J. Blenis,et al.  Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression , 2004, Oncogene.

[4]  R. Schmidt,et al.  Alternating metabolic pathways in NGF-deprived sympathetic neurons affect caspase-independent death , 2003, The Journal of cell biology.

[5]  P. Maher,et al.  The Regulation of Glucose Metabolism by HIF-1 Mediates a Neuroprotective Response to Amyloid Beta Peptide , 2003, Neuron.

[6]  D. Hardie,et al.  Management of cellular energy by the AMP‐activated protein kinase system , 2003, FEBS letters.

[7]  Subramanian Rajagopalan,et al.  Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo A Novel Therapy for Parkinson's Disease , 2003, Neuron.

[8]  Konstantine K. Zakzanis,et al.  A Meta-Analysis of Structural and Functional Brain Imaging in Dementia of the Alzheimer's Type: A Neuroimaging Profile , 2003, Neuropsychology Review.

[9]  J. Bamburg,et al.  Actin-ATP Hydrolysis Is a Major Energy Drain for Neurons , 2003, The Journal of Neuroscience.

[10]  D. Attwell,et al.  The neural basis of functional brain imaging signals , 2002, Trends in Neurosciences.

[11]  U. Rauen,et al.  Enhancement of iron toxicity in L929 cells by D-glucose: accelerated(re-)reduction. , 2002, The Biochemical journal.

[12]  J. LaManna,et al.  Activation of Hypoxia-Inducible Factor-1 in the Rat Cerebral Cortex after Transient Global Ischemia: Potential Role of Insulin-Like Growth Factor-1 , 2002, The Journal of Neuroscience.

[13]  G. Semenza.  Signal transduction to hypoxia-inducible factor 1. , 2002, Biochemical pharmacology.

[14]  R. Wenger,et al.  Cellular adaptation to hypoxia: O2‐sensing protein hydroxylases, hypoxia‐inducible transcription factors, and O2‐regulated gene expression , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  M. Raichle,et al.  Appraising the brain's energy budget , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[16]  U. Dirnagl,et al.  Desferrioxamine Induces Delayed Tolerance against Cerebral Ischemia in Vivo and in Vitro , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  L. Poellinger,et al.  The dietary flavonoid quercetin modulates HIF-1 alpha activity in endothelial cells. , 2002, Biochemical and biophysical research communications.

[18]  C. Thompson,et al.  Cell metabolism in the regulation of programmed cell death , 2002, Trends in Endocrinology & Metabolism.

[19]  Gary Fiskum,et al.  Generation of reactive oxygen species by the mitochondrial electron transport chain , 2002, Journal of neurochemistry.

[20]  M. Demedts,et al.  Activation of the hexose monophosphate shunt in rat type II pneumocytes as an early marker of oxidative stress caused by cobalt particles , 2002, Archives of Toxicology.

[21]  H. Pinedo,et al.  Induction of Vascular Endothelial Growth Factor Expression and Hypoxia-inducible Factor 1α Protein by the Oxidative Stressor Arsenite* , 2001, The Journal of Biological Chemistry.

[22]  J. Blass.  Brain metabolism and brain disease: Is metabolic deficiency the proximate cause of Alzheimer dementia? , 2001, Journal of neuroscience research.

[23]  Peter Lipton,et al.  Do active cerebral neurons really use lactate rather than glucose? , 2001, Trends in Neurosciences.

[24]  M. Cynader,et al.  Pyruvate Released by Astrocytes Protects Neurons from Copper-Catalyzed Cysteine Neurotoxicity , 2001, The Journal of Neuroscience.

[25]  C. Masters,et al.  Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice , 2001, Neuron.

[26]  P. Thibault,et al.  Transcription Factor HIF-1 Is a Necessary Mediator of the Pasteur Effect in Mammalian Cells , 2001, Molecular and Cellular Biology.

[27]  M. Beal,et al.  Metal Chelator Decreases Alzheimer β-Amyloid Plaques , 2001, Neuron.

[28]  C. Finch,et al.  Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum? , 2001, Trends in Neurosciences.

[29]  R. Sapolsky,et al.  Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. , 2000, Archives of general psychiatry.

[30]  C. Ryan,et al.  Why is learning and memory dysfunction in Type 2 diabetes limited to older adults? , 2000, Diabetes/metabolism research and reviews.

[31]  N. Chandel,et al.  Reactive Oxygen Species Generated at Mitochondrial Complex III Stabilize Hypoxia-inducible Factor-1α during Hypoxia , 2000, The Journal of Biological Chemistry.

[32]  Peter Gergely,et al.  Stimulation of the pentose phosphate pathway and glutathione levels by dehydroascorbate, the oxidized form of vitamin C , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  Y. Stern,et al.  Diabetes mellitus and the risk of dementia , 1999, Neurology.

[34]  G. Semenza,et al.  Protection from Oxidative Stress–Induced Apoptosis in Cortical Neuronal Cultures by Iron Chelators Is Associated with Enhanced DNA Binding of Hypoxia-Inducible Factor-1 and ATF-1/CREB and Increased Expression of Glycolytic Enzymes, p21waf1/cip1, and Erythropoietin , 1999, The Journal of Neuroscience.

[35]  R. L. Russell,et al.  Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease. , 1999, Archives of biochemistry and biophysics.

[36]  S. Filosa,et al.  Enhanced Glutathione Levels and Oxidoresistance Mediated by Increased Glucose-6-phosphate Dehydrogenase Expression* , 1999, The Journal of Biological Chemistry.

[37]  M. Mattson,et al.  Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults , 1999, Annals of neurology.

[38]  P. Maher,et al.  The Regulation of Reactive Oxygen Species Production during Programmed Cell Death , 1998, The Journal of cell biology.

[39]  K. Brand.  Aerobic Glycolysis by Proliferating Cells: Protection against Oxidative Stress at the Expense of Energy Yield , 1997, Journal of bioenergetics and biomembranes.

[40]  P Woodbury,et al.  A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. , 1997, The New England journal of medicine.

[41]  A. Parpura-Gill,et al.  The inhibitory effects of β-amyloid on glutamate and glucose uptakes by cultured astrocytes , 1997, Brain Research.

[42]  Karl Brand,et al.  Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species 1 , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  G. Martini,et al.  A new lease of life for an old enzyme , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.

[44]  Y. Sheline,et al.  Memory improvement following induced hyperinsulinemia in alzheimer's disease , 1996, Neurobiology of Aging.

[45]  C. Behl,et al.  Increased antioxidant enzyme activity in amyloid beta protein-resistant cells , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[46]  D. Schubert,et al.  The role of iron in beta amyloid toxicity. , 1995, Biochemical and biophysical research communications.

[47]  P. Pandolfi,et al.  Targeted disruption of the housekeeping gene encoding glucose 6‐phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress. , 1995, The EMBO journal.

[48]  C. Behl,et al.  Amyloid peptides are toxic via a common oxidative mechanism. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[49]  P. E. Gold,et al.  Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer's type , 1993, Neurobiology of Aging.

[50]  C. Behl,et al.  Heat shock partially protects rat pheochromocytoma PC12 cells from amyloid β peptide toxicity , 1993, Neuroscience Letters.

[51]  G. Cole,et al.  Vitamin E protects nerve cells from amyloid βprotein toxicity , 1992 .

[52]  D. Schubert,et al.  Insulin-like growth factor 1 supports embryonic nerve cell survival. , 1990, Biochemical and biophysical research communications.

[53]  D. Kirschner,et al.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.

[54]  G. Zelenock,et al.  Insulin administration protects neurologic function in cerebral ischemia in rats. , 1988, Stroke.

[55]  D. Neary,et al.  Mitochondrial function in brain tissue in primary degenerative dementia , 1987, Brain Research.

[56]  N. Sims,et al.  [14C]acetylcholine synthesis and [14C]carbon dioxide production from [U-14C]glucose by tissue prisms from human neocortex. , 1981, The Biochemical journal.

[57]  W. Meier-Ruge,et al.  ACCELERATED AGEING OR SELECTIVE NEURONAL LOSS AS AN IMPORTANT CAUSE OF DEMENTIA? , 1979, The Lancet.

[58]  D. Davies,et al.  Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's disease , 2004, Virchows Archiv.

[59]  David Carling,et al.  The AMP-activated protein kinase cascade--a unifying system for energy control. , 2004, Trends in biochemical sciences.

[60]  S. Craft,et al.  The Role of Insulin Resistance in the Pathogenesis of Alzheimer’s Disease , 2003, CNS drugs.

[61]  D. Dwyer,et al.  Expression, regulation, and functional role of glucose transporters (GLUTs) in brain. , 2002, International review of neurobiology.

[62]  A. M. Palmer,et al.  The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease , 1999, Journal of Neural Transmission.

[63]  R. Moreno-Sánchez,et al.  Intermediary metabolism of fast-growth tumor cells. , 1998, Archives of medical research.

[64]  C. Behl,et al.  Hydrogen peroxide mediates amyloid beta protein toxicity. , 1994, Cell.

[65]  E. Masliah,et al.  Structural basis of the cognitive alterations in Alzheimer disease. , 1994 .